Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-24-094244
Filing Date
2024-11-04
Accepted
2024-11-04 18:20:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea0219947-13ga1felix_nlsphar.htm SC 13G/A 70909
  Complete submission text file 0001213900-24-094244.txt   72244
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Subject) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92065 | Film No.: 241425025
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NLS PHARMACEUTICS LTD. THE CIRCLE 6 ZURICH V8 8058
Business Address
Grisard Felix (Filed by) CIK: 0001966808 (see all company filings)

Type: SC 13G/A